In 24 heavily pre-treated patients with advanced primary cutaneous melanoma whose cancer had progressed after multiple prior lines of therapy including anti-PD-1 therapy, data continue to show an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results